Agios Pharmaceuticals

Agios is a commercial-stage biopharmaceutical company dedicated to redefining the future of rare disease treatment.

Fueled by connections, we build trusted partnerships with rare disease communities, collaborating to develop and deliver innovative medicines with the potential to transform lives.

Rooted in hematology, we combine deep biological expertise with real-world insights to advance a growing pipeline of medicines that reflect the priorities of rare disease communities.

Our inclusive, collaborative culture sparks bold thinking and strengthens our connections – with each other and with the people we serve. Review our social media guidelines: https://www.agios.com/community-guidelines/